Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity

Details for Australian Patent Application No. 2003223755 (hide)

Owner Merck & Co., Inc. Merck Sharp & Dohme Limited

Inventors Guiadeen, Deodialsingh; Morriello, Gregori; Butora, Gabor; Jiao, Richard; Goble, Stephen, D.; Yang, Lihu; Zhou, Changyou; Mills, Sander, G.; Moyes, Christopher; Pasternak, Alexander; Kothandaraman, Shankaran

Agent Spruson & Ferguson

Pub. Number AU-B-2003223755

PCT Number PCT/US03/13121

PCT Pub. Number WO2003/093231

Priority 60/376,407 29.04.02 US

Filing date 25 April 2003

Wipo publication date 17 November 2003

Acceptance publication date 21 August 2008

International Classifications

C07D 217/04 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/4725 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 33/10 (2006.01) Antiparasitic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 217/06 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 491/052 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 493/08 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/376,407 29.04.02 US

8 January 2004 Application Open to Public Inspection

  Published as AU-B-2003223755

21 August 2008 Application Accepted

  Published as AU-B-2003223755

18 December 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend co-patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003223756-SURFACTANT-AMMONIUM SULFATE ADJUVANT COMPOSITION FOR ENHANCING EFFICACY OF HERBICIDES

2003223754-4-azasteroid derivatives as androgen receptor modulators